Author

Kenneth C Levenson

Emory University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Antonis AthanasiadisiD· 3 shared Eleftherios MichailidisiD· 3 shared Allan Henrique Depieri CataneoiD· 2 shared Catherine A. FreijeiD· 2 shared Charles M. RiceiD· 2 shared Chenhui Zou· 2 shared Corrine QuirkiD· 2 shared Dar-Yin LiiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Antonis AthanasiadisORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A novel proviral mechanism for the ISG, Shiftless, during human coronavirus infection

Taylor M. Shue, Georgios Mourtzouchos, Dar-Yin Li, Yee Tsuey Ong, Antonis Athanasiadis, Maria Bousali, Madeleine K Sanders, Sophie N. Spector, Christopher Rivera-Bonilla, Khadija Ndoye, Kenneth C Levenson, J. Cuba, J Harris, Kelly Mieck, Shuiyun Lan, , Eleftherios Michailidis

This study reveals that the ISG Shiftless (SHFL) has both antiviral and proviral functions during coronavirus infection, enhancing susceptibility while modulating IFN signaling.

bioRxiv · Oct 31, 2026 · PreprintMicrobiology

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors

Ansgar F. Stenzel, Antonis Athanasiadis, Georgios Dangas, Paul Park, Anthi Maslarinou, Evgenia Moschogianni, Allan Henrique Depieri Cataneo, Catherine A. Freije, Yichen Zhou, Kenneth C Levenson, Corrine Quirk, Chenhui Zou, William M. Schneider, Adriano Aguzzi, Charles M. Rice, , Eleftherios Michailidis

The paper develops CRISPR-Cas9 delivery methods for primary human hepatocytes to enable efficient gene editing and screening of HBV host factors.

bioRxiv · Aug 18, 2026 · PreprintGenomics

Orthogonal CRISPR screens and human liver chimeric mice identify hepatitis B virus host factors

Catherine A. Freije, Georgios Dangas, Antonis Athanasiadis, Evgenia Moschogianni, Madeleine K Sanders, Allan Henrique Depieri Cataneo, Chloe K. Boehm, Maria Bousali, Dar-Yin Li, Sooyoung Lee, Guillaume Cornelis, Gary Lo, Leah B. Soriaga, Amalio Telenti, Julia di Iulio, , Eleftherios Michailidis

The paper identifies HBV host factors using CRISPR screens and human liver chimeric mice, finding that EXOC1 is antiviral and ZCCHC14 is proviral.

bioRxiv · Jul 24, 2026 · PreprintMicrobiology